Last reviewed · How we verify
NCT06937736
Performance Evaluation by the User of BGM Contour Care According to ISO 15197:2015
NA trial testing blood glucose measurement by subject in Diabetes in 101 participants. Completed in 23 July 2024.
16 July 2024
Quick facts
| Lead sponsor | Institut fur Diabetes Karlsburg GmbH |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 101 |
| Start date | 20 June 2024 |
| Primary completion | 16 July 2024 |
| Estimated completion | 23 July 2024 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- blood glucose measurement by subject
Conditions studied
- Diabetes — all drugs for Diabetes →
Sponsor
Institut fur Diabetes Karlsburg GmbH
Who can join
18 and older, any sex, with Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Performance Evaluation by the User of the Blood Glucose Monitoring SystemContour Care in accordance with DIN EN ISO 15197:2015
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06937736
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of blood glucose measurement by subject
Trials testing the same drug.
- NCT06037538 — User Evaluation of BGM JS200B · NA · completed
Other recruiting trials for Diabetes
Currently open trials in the same condition.
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07417865 — ECHO Diabetes FQHC · recruiting
Other Institut fur Diabetes Karlsburg GmbH trials
Trials by the same sponsor.
- NCT07353125 — System Accuracy and Performance Evaluation by the User of BGM LS-9 · NA · completed
- NCT06146933 — System Accuracy of BGM GL22 · NA · completed
- NCT06037551 — System Accuracy of the Blood Glucose Monitor for Personal Use Contour Care · NA · completed
- NCT06037538 — User Evaluation of BGM JS200B · NA · completed
- NCT06037512 — User Evaluation of BGM VGM77 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06937736 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut fur Diabetes Karlsburg GmbH
- Last refreshed: 22 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06937736.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing